|
Volumn 348, Issue 13, 2003, Pages 1284-1286
|
Atrial fibrillation - Rate versus rhythm control [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIODARONE;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
SOTALOL;
STATINE DERIVATIVE;
WARFARIN;
ANTICOAGULATION;
ANTIHYPERTENSIVE THERAPY;
ATHEROSCLEROSIS;
BLEEDING;
CARDIOVERSION;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CORONARY ARTERY DISEASE;
DOSE RESPONSE;
DRUG FATALITY;
FOLLOW UP;
HEART ATRIUM FIBRILLATION;
HEART ATRIUM THROMBOSIS;
HEART INFARCTION;
HEART RATE;
HEART RHYTHM;
HUMAN;
HYPERTENSION;
LETTER;
LOW DRUG DOSE;
LUNG TOXICITY;
PRIORITY JOURNAL;
PROGNOSIS;
RISK FACTOR;
STROKE;
SURVIVAL;
THROMBOEMBOLISM;
THROMBOGENESIS;
TOXICITY;
TREATMENT OUTCOME;
METHODOLOGY;
NOTE;
AORTA VALVE STENOSIS;
PATHOPHYSIOLOGY;
ADRENERGIC BETA-ANTAGONISTS;
ATRIAL FIBRILLATION;
ELECTRIC COUNTERSHOCK;
HEART RATE;
HUMAN;
RESEARCH DESIGN;
HUMANS;
AORTIC VALVE STENOSIS;
|
EID: 0037468919
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200303273481314 Document Type: Letter |
Times cited : (4)
|
References (0)
|